Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Jordan M. Hyatt, Kathleen Powell, Nicolette K. Bell, K. Bret Bucklen & Daniel Langleben. (2023) Assessment of Attitudes Towards Medication-Assisted Drug Treatment Options among an Incarcerated Population. Corrections 8:4, pages 344-370.
Read now
Read now
Emmeline N. Taylor, Christine Timko, Ingrid A. Binswanger, Alex H. S. Harris, Matthew Stimmel, David Smelson & Andrea K. Finlay. (2022) A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration. Substance Abuse 43:1, pages 556-563.
Read now
Read now
Steven D. Shirk, Victoria Ameral, Shane W. Kraus, Joseph Houchins, Megan Kelly, Kendra Pugh, Erin Reilly & Nitigna Desai. (2021) Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A Retrospective Chart Review. Journal of Dual Diagnosis 17:3, pages 207-215.
Read now
Read now
Yang Yang, Julie Gray, George W. Joe, Patrick M. Flynn & Kevin Knight. (2019) Treatment Retention Satisfaction, and Therapeutic Progress for Justice-Involved Individuals Referred to Community-Based Medication-Assisted Treatment. Substance Use & Misuse 54:9, pages 1461-1474.
Read now
Read now
Matthew W. Logan & Nathan W. Link. (2019) Taking Stock of Drug Courts: Do They Work?. Victims & Offenders 14:3, pages 283-298.
Read now
Read now
Michael Fendrich & Thomas P. LeBel. (2019) Implementing access to medication assisted treatment in a drug treatment court: Correlates, consequences, and obstacles. Journal of Offender Rehabilitation 58:3, pages 178-198.
Read now
Read now
Robert P. Schwartz, Mary M. Mitchell, Kevin E. O’Grady, Sharon M. Kelly, Jan Gryczynski, Shannon Gwin Mitchell, Michael S. Gordon & Jerome H. Jaffe. (2018) Pharmacotherapy for opioid addiction in community corrections. International Review of Psychiatry 30:5, pages 117-135.
Read now
Read now
S. B. Carswell, M. S. Gordon, J. Gryczynski & S. A. Tangires. (2018) The daily progress system: A proof of concept pilot study of a recovery support technology tool for outpatient substance abuse treatment. The American Journal of Drug and Alcohol Abuse 44:3, pages 294-301.
Read now
Read now
Richard N Rosenthal & Viral V Goradia. (2017) Advances in the delivery of buprenorphine for opioid dependence. Drug Design, Development and Therapy 11, pages 2493-2505.
Read now
Read now
Eduardo R. Butelman & Mary Jeanne Kreek. (2017) Medications for substance use disorders (SUD): emerging approaches. Expert Opinion on Emerging Drugs 22:4, pages 301-315.
Read now
Read now
Christine Timko, Nicole R. Schultz, Michael A. Cucciare, Lisa Vittorio & Christina Garrison-Diehn. (2016) Retention in medication-assisted treatment for opiate dependence: A systematic review. Journal of Addictive Diseases 35:1, pages 22-35.
Read now
Read now
Sarah J. Cousins, Loretta Denering, Desirée Crèvecoeur-MacPhail, John Viernes, Wayne Sugita, James Barger, Tina Kim, Stefanie Weimann & Richard A. Rawson. (2016) A demonstration project implementing extended-release naltrexone in Los Angeles County. Substance Abuse 37:1, pages 54-62.
Read now
Read now
Sarah E. Wakeman & Josiah D. Rich. (2015) Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based Care. Journal of Addictive Diseases 34:2-3, pages 220-225.
Read now
Read now
Michael S. Gordon, Timothy W. Kinlock, Robert P. Schwartz, Kathryn A. Couvillion, Laura J. Sudec, Kevin E. O’Grady, Frank J. Vocci & Hamin Shabazz. (2015) Buprenorphine Treatment for Probationers and Parolees. Substance Abuse 36:2, pages 217-225.
Read now
Read now
Articles from other publishers (30)
Rebecca C. Rossom, A. Lauren Crain, Patrick J. O'Connor, Eric Wright, Irina V. Haller, Stephanie A. Hooker, JoAnn M. Sperl-Hillen, Anthony Olson, Katrina Romagnoli, Leif Solberg, Steven P. Dehmer, Jacob Haapala, Caitlin Borgert-Spaniol, Lorraine Tusing, Jule Muegge, Clayton Allen, Heidi Ekstrom, Kristen Huntley, Jennifer McCormack & Gavin Bart. (2023) Design of a pragmatic clinical trial to improve screening and treatment for opioid use disorder in primary care. Contemporary Clinical Trials 124, pages 107012.
Crossref
Crossref
Rebecca C. Rossom, JoAnn M. Sperl-Hillen, Patrick J. O’Connor, A. Lauren Crain, Laurel Nightingale, Anne Pylkas, Kristen V. Huntley & Gavin Bart. (2021) A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder. Addiction Science & Clinical Practice 16:1.
Crossref
Crossref
Marian Jarlenski, Joo Yeon Kim, Katherine A. Ahrens, Lindsay Allen, Anna Austin, Andrew J. Barnes, Dushka Crane, Paul Lanier, Rachel Mauk, Shamis Mohamoud, Nathan Pauly, Jeffrey Talbert, Kara Zivin & Julie M. Donohue. (2021) Healthcare Patterns of Pregnant Women and Children Affected by OUD in 9 State Medicaid Populations. Journal of Addiction Medicine 15:5, pages 406-413.
Crossref
Crossref
Jordan M. Hyatt & Philipp P. Lobmaier. (2020) Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation. Health & Justice 8:1.
Crossref
Crossref
Michael D. Raleigh, Claudia Accetturo & Marco Pravetoni. (2020) Combining a Candidate Vaccine for Opioid Use Disorders with Extended-Release Naltrexone Increases Protection against Oxycodone-Induced Behavioral Effects and Toxicity. Journal of Pharmacology and Experimental Therapeutics 374:3, pages 392-403.
Crossref
Crossref
Andrea K. Finlay, Erica Morse, Matthew Stimmel, Emmeline Taylor, Christine Timko, Alex H. S. Harris, David Smelson, Mengfei Yu, Jessica Blue-Howells & Ingrid A. Binswanger. (2020) Barriers to Medications for Opioid Use Disorder Among Veterans Involved in the Legal System: a Qualitative Study. Journal of General Internal Medicine 35:9, pages 2529-2536.
Crossref
Crossref
. (2020) The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update. Journal of Addiction Medicine 14:2S, pages 1-91.
Crossref
Crossref
Melissa Velasquez, Mara Flannery, Ryan Badolato, Alexandria Vittitow, Ryan D. McDonald, Babak Tofighi, Ann R. Garment, Jonathan Giftos & Joshua D. Lee. (2019) Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail. Addiction Science & Clinical Practice 14:1.
Crossref
Crossref
George R. Uhl, George F. Koob & Jennifer Cable. (2019) The neurobiology of addiction. Annals of the New York Academy of Sciences 1451:1, pages 5-28.
Crossref
Crossref
Arthur Robin Williams, Vincent Barbieri, Kaitlyn Mishlen, Frances R. Levin, Edward V. Nunes, John J. Mariani & Adam Bisaga. (2017) Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders. The American Journal on Addictions 26:4, pages 319-325.
Crossref
Crossref
Michael S. Gordon, Frank J. Vocci, Terrence T. Fitzgerald, Kevin E. O'Grady & Charles P. O'Brien. (2017) Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment. Contemporary Clinical Trials 53, pages 130-136.
Crossref
Crossref
Paul Crits-Christoph, Hannah M. Markell, Mary Beth Connolly Gibbons, Robert Gallop, Christie Lundy, Mark Stringer & David R. Gastfriend. (2016) A Naturalistic Evaluation of Extended-Release Naltrexone in Clinical Practice in Missouri. Journal of Substance Abuse Treatment 70, pages 50-57.
Crossref
Crossref
Sarah J. Cousins, Seyed Ramin Radfar, Desirée Crèvecoeur-MacPhail, Alfonso Ang, Kendall Darfler & Richard A. Rawson. (2016) Predictors of Continued Use of Extended-Released Naltrexone (XR-NTX) for Opioid-Dependence: An Analysis of Heroin and Non-Heroin Opioid Users in Los Angeles County. Journal of Substance Abuse Treatment 63, pages 66-71.
Crossref
Crossref
Joshua D. Lee, Peter D. Friedmann, Timothy W. Kinlock, Edward V. Nunes, Tamara Y. Boney, Randall A. HoskinsonJr.Jr., Donna Wilson, Ryan McDonald, John Rotrosen, Marc N. Gourevitch, Michael Gordon, Marc Fishman, Donna T. Chen, Richard J. Bonnie, James W. Cornish, Sean M. Murphy & Charles P. O’Brien. (2016) Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders. New England Journal of Medicine 374:13, pages 1232-1242.
Crossref
Crossref
Andrea K. Finlay, Alex H.S. Harris, Joel Rosenthal, Jessica Blue-Howells, Sean Clark, Jim McGuire, Christine Timko, Susan M. Frayne, David Smelson, Elizabeth Oliva & Ingrid Binswanger. (2016) Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients. Drug and Alcohol Dependence 160, pages 222-226.
Crossref
Crossref
Aaron D Fox, Jeronimo Maradiaga, Linda Weiss, Jennifer Sanchez, Joanna L Starrels & Chinazo O Cunningham. (2015) Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder. Addiction Science & Clinical Practice 10:1.
Crossref
Crossref
Michael S. Gordon, Timothy W. Kinlock, Frank J. Vocci, Terrence T. Fitzgerald, Asli Memisoglu & Bernard Silverman. (2015) A Phase 4, Pilot, Open-Label Study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for Prisoners. Journal of Substance Abuse Treatment 59, pages 52-58.
Crossref
Crossref
Paul Crits-Christoph, Christie Lundy, Mark Stringer, Robert Gallop & David R. Gastfriend. (2015) Extended-Release Naltrexone for Alcohol and Opioid Problems in Missouri Parolees and Probationers. Journal of Substance Abuse Treatment 56, pages 54-60.
Crossref
Crossref
Amanda E Perry, Matthew Neilson, Marrissa Martyn-St James, Julie M Glanville, Rebecca Woodhouse & Catherine Hewitt. (2015) Interventions for female drug-using offenders. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Amanda E Perry, Matthew Neilson, Marrissa Martyn-St James, Julie M Glanville, Rebecca Woodhouse, Christine Godfrey & Catherine Hewitt. (2015) Interventions for drug-using offenders with co-occurring mental illness. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Amanda E Perry, Matthew Neilson, Marrissa Martyn-St James, Julie M Glanville, Rebecca Woodhouse, Christine Godfrey & Catherine Hewitt. (2015) Pharmacological interventions for drug-using offenders. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Joshua D. Lee, Ryan McDonald, Ellie Grossman, Jennifer McNeely, Eugene Laska, John Rotrosen & Marc N. Gourevitch. (2015) Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial. Addiction 110:6, pages 1008-1014.
Crossref
Crossref
Joshua D. Lee, Peter D. Friedmann, Tamara Y. Boney, Randall A. HoskinsonJr.Jr., Ryan McDonald, Michael Gordon, Marc Fishman, Donna T. Chen, Richard J. Bonnie, Timothy W. Kinlock, Edward V. Nunes, James W. Cornish & Charles P. O'Brien. (2015) Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: Rationale and design of a randomized controlled effectiveness trial. Contemporary Clinical Trials 41, pages 110-117.
Crossref
Crossref
Angela Di Paola, Thomas Lincoln, Daniel J. Skiest, Maureen Desabrais, Frederick L. Altice & Sandra A. Springer. (2014) Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community. Contemporary Clinical Trials 39:2, pages 256-268.
Crossref
Crossref
Nikolaj Kunøe, Philipp Lobmaier, Hanh Ngo & Gary Hulse. (2014) Injectable and implantable sustained release naltrexone in the treatment of opioid addiction. British Journal of Clinical Pharmacology 77:2, pages 264-271.
Crossref
Crossref
Amanda E Perry, Matthew Neilson, Marrissa Martyn-St James, Julie M Glanville, Rachael McCool, Steven Duffy, Christine Godfrey & Catherine Hewitt. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Richard J. Bodnar. (2013) Endogenous opiates and behavior: 2012. Peptides 50, pages 55-95.
Crossref
Crossref
Steven Belenko, Matthew Hiller & Leah Hamilton. (2013) Treating Substance Use Disorders in the Criminal Justice System. Current Psychiatry Reports 15:11.
Crossref
Crossref
Karen L. Cropsey, Peter S. Lane, Adam C. Perkins, C. Brendan Clark, Sonya Hardy, C. McCullumsmith & Maxine L. Stitzer. (2013) Buprenorphine and Medication Management in a Community Corrections Population. Journal of Addiction Medicine 7:3, pages 210-215.
Crossref
Crossref
Donna M. Coviello, Dave A. Zanis, Susan A. Wesnoski, Nicole Palman, Arona Gur, Kevin G. Lynch & James R. McKay. (2013) Does mandating offenders to treatment improve completion rates?. Journal of Substance Abuse Treatment 44:4, pages 417-425.
Crossref
Crossref